14 March 2017
Virginia
Reporter: Barney Dixon
PTAB upholds Acorda patents
Hedge fund manager Kyle Bass has lost a US Patent Trial and Appeal Board (PTAB) inter-partes review that sought to invalidate four patents belonging to Acorda Therapeutics.

The patents relate to Acorda’s Ampyra drug, which is aimed at improving walking for adults with multiple sclerosis.

Bass filed the claim through his Coalition for Affordable Drugs, and argued that all four patents should be held invalid as unpatentable.

But in its 9 March decision, the PTAB said that it was “not persuaded” by Bass’s arguments and he had not “demonstrated by a preponderance of evidence the challenged claims are unpatentable on the instituted grounds”.

Ron Cohen, president and CEO of Acorda, said: “The court decision reflects the merits of the case we presented and the validity and strength of our intellectual property for Ampyra.”

“Medical innovation depends on the recognition of valid intellectual property claims.”

He added: “[We] will continue to defend the validity of our intellectual property rights for Ampyra.”

These four patents, as well as another relating to Ampyra, have also been challenged in the US District Court for the District of Delaware, but the court has yet to issue its decision.

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Microsoft and Toyota connect over cars
23 March 2017 | Washington | Reporter: Barney Dixon
The deal will consolidate Microsoft software and Toyota hardware
IPO Pakistan and SIPO agree to MOU
23 March 2017 | Islamabad | Reporter: Barney Dixon
The deal will ensure high levels of cooperation in patent examination
SCOTUS weakens laches as a defence
22 March 2017 | Washington DC | Reporter: Barney Dixon
Laches cannot be invoked as a defence against a claim for damages brought within the six-year limitations period, according to a new ruling from the US Supreme Court
USITC to investigate LG
21 March 2017 | Washington DC | Reporter: Barney Dixon
The US International Trade Commission has instituted an investigation into four technology companies, including LG
IPSO asks Germany to step into EPO dispute
21 March 2017 | Munich | Reporter: Barney Dixon
The International and European Public Services Organisation has penned a letter to German Chancellor Angela Merkel raising its “extreme concern” with the European Patent Office
Lewis Roca Rothgerber hires of counsel
21 March 2017 | Los Angeles | Reporter: Barney Dixon
Lewis Roca Rothgerber Christie has hired Holly Logue as of counsel in its intellectual property practice group
SCOTUS to decide patent exhaustion question
20 March 2017 | Washington DC | Reporter: Barney Dixon
The US Supreme Court will hear oral arguments tomorrow (21 March) in the much-anticipated Impression Products v Lexmark International litigation, as justices grapple with one of the more uncertain areas of US patent law